Search
for
Sort by
Research 601–630 of 777
- Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
- Prevalence of depression and anxiety in women with polycystic ovary syndrome (PCOS) and associated factors in a quaternary hospital in Thailand: a cross-sectional study
- Role of Oxidative Stress in Obese and Nonobese PCOS Patients
- Stanowisko Polskiego Towarzystwa Endokrynologicznego, Polskiego Towarzystwa Ginekologów i Położników oraz Polskiego Towarzystwa Endokrynologii Ginekologicznej w sprawie diagnostyki i leczenia zespołu policystycznych jajników
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review
- 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
- The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study
- Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
- Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter’s Methylation in AFAB People
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the presence of polycystic ovary syndrome in Caucasian women
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set
- PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment
- Cutaneous manifestation of polycystic ovary syndrome
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- Prevalence of and Risk Factors Associated with Polycystic Ovary Syndrome Among Female University Students of Health Sciences in a Middle Eastern Country
- Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age
- Update on polycystic ovary syndrome
- Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study